Fischer Medical Ventures Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 5.35 | 5.87 | 0.87 |
| Operating Expense | 4.17 | 6.78 | 0.21 |
| Net Profit | -0.61 | -0.89 | 0.20 |
| Net Profit Margin | -11.40 | -15.16 | 22.99 |
| Earning Per Share | -0.09 | -0.06 | 0.04 |
| EBIDTA | 0.78 | -0.64 | 0.66 |
| Effective Tax Rate | TBA | -3.30 | 63.64 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 5.35 |
| Operating Expense | 4.17 |
| Net Profit | -0.61 |
| Net Profit Margin | -11.40 |
| Earning Per Share | -0.09 |
| EBIDTA | 0.78 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 5.22 | 11.53 | 0.18 |
| Operating Expenses Annual | 7.46 | 11.72 | 0.16 |
| Operating Profit Annual | 1.22 | 0.56 | 0.02 |
| Interest Annual | 0.13 | 0.02 | 0.02 |
| Depreciation | 0.00 | 0.00 | TBA |
| Net Profit Annual | 0.66 | 0.40 | -0.04 |
| Tax Annual | 0.30 | 0.14 | 0.04 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 5.22 |
| Operating Expenses Annual | 7.46 |
| Operating Profit Annual | 1.22 |
| Interest Annual | 0.13 |
| Depreciation | 0.00 |
| Net Profit Annual | 0.66 |
| Tax Annual | 0.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | TBA | 0.04 | 0.02 |
| Cash Flow from Operations | -24.10 | 0.08 | -0.15 |
| Cash Flow from Investing | -231.79 | -37.78 | TBA |
| Cash Flow from Financing | 256.18 | 37.67 | 0.17 |
| Cash Flow at the End | 0.29 | TBA | 0.04 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | TBA |
| Cash Flow from Operations | -24.10 |
| Cash Flow from Investing | -231.79 |
| Cash Flow from Financing | 256.18 |
| Cash Flow at the End | 0.29 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 23.37 | 4.86 | 11.11 |
| PBIT Margin (%) | 20.88 | 4.86 | 11.11 |
| PBT Margin (%) | -139.66 | -237.98 | -544.45 |
| Net PROFIT Margin (%) | 12.64 | 3.47 | -22.22 |
| Return On Networth / Equity (%) | 0.32 | 1.01 | TBA |
| Return On Networth /Employed (%) | 0.50 | 1.40 | TBA |
| Return On Assets (%) | 0.25 | 1.01 | -17.11 |
| Total Debt / Equity (X) | 0.05 | 0.01 | TBA |
| Asset Turnover Ratio (%) | 0.02 | 0.29 | 0.77 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 23.37 |
| PBIT Margin (%) | 20.88 |
| PBT Margin (%) | -139.66 |
| Net PROFIT Margin (%) | 12.64 |
| Return On Networth / Equity (%) | 0.32 |
| Return On Networth /Employed (%) | 0.50 |
| Return On Assets (%) | 0.25 |
| Total Debt / Equity (X) | 0.05 |
| Asset Turnover Ratio (%) | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.68 | 0.01 | TBA |
| Total Current Assets Annual | 27.55 | 50.54 | 0.25 |
| Non Current Assets Annual | 330.96 | 41.29 | 0.11 |
| Total Shareholders Funds Annual | 335.69 | 79.68 | -0.27 |
| Total Assets Annual | 358.50 | 91.83 | 0.35 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.68 |
| Total Current Assets Annual | 27.55 |
| Non Current Assets Annual | 330.96 |
| Total Shareholders Funds Annual | 335.69 |
| Total Assets Annual | 358.50 |
EPS (INR)
Expected
0.94
Reported
0.09
Surprise
-90.43%
Mar 2025
EPS beaten by -90.43%
Dec 2024
EPS beaten by -120.83%
Sep 2024
EPS beaten by 0.00%
